OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Cardiology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
The role of artificial intelligence in early detection and intervention of coronary artery disease	31
Editorial: from albuminuria to uric acid – emerging risk factors beyond lipids	21
Editorial introductions	20
Assessment and management of neonates with unrepaired congenital heart disease	20
REVIVED BCIS-2: update and key learnings	19
Vascular regenerative cells in cardiometabolic disease	19
Device therapy for heart failure management	17
Pemafibrate and other triglyceride-lowering therapies to reduce risk of cardiovascular and metabolic disease	17
Editorial introductions	15
Editorial introductions	15
Advances in device-based therapies for cardiorenal syndrome	15
Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular care	14
Donation after circulatory determination of death in heart transplant: impact on current and future allocation policy	13
Cardiac phenotypes in LMNA mutations	13
Clinical considerations and pathophysiological associations among obesity, weight loss, heart failure, and hypertension	13
Radiofrequency lesion formation prediction with contact force versus local impedance	12
Multimodality cardiovascular imaging in hypertension	12
Wellness and burnout in cardiac surgery: not black and white	12
Imaging of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy	12
Near infrared spectroscopy in the pediatric cardiac intensive care unit: accurately interpreting the data	11
Management of hypertension in heart transplant recipients: an ongoing conundrum	11
Sleep apnea and cardiovascular risk	11
Editorial introductions	11
Bicuspid aortic valve associated aortopathy: 2022 guideline update	11
Cardiac selectivity in pulsed field ablation	11

Integration of palliative care across the spectrum of heart failure care and therapies: considerations, contemporary data, and challenges	10
Is the world ready for the STICH 3.0 trial?	10
Weight loss and atrial fibrillation: a review	9
The mitral valve in hypertrophic cardiomyopathy	9
Management of difficult coronary anatomy during transcatheter aortic valve implantation: what are the key issues?	9
Fetal MRI for cardiopulmonary anomalies: what the pediatric cardiologist and surgeon need to know	9
Impact of glucagon-like peptide-1 receptor agonists on hypertension management: a narrative review	9
Expanding revascularization trials to women and underserved minorities and shifting to patient-centered outcomes: RECHARGE trials program	9
Mapping and ablation of intramural premature ventricular complexes: state-of-the-art review	9
Electrographic flow mapping of atrial fibrillation	8
Bad behavior in healthcare: an insidious threat to patients, staff, and organizations	8
Albuminuria and cardiorenal risk	8
Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?	8
Tumours of the heart valves	8
2025 ESC/EACTS valvular heart disease guidelines: key updates and surgical implications for cardiac surgeons	8
Robotic mitral valve surgery: evolving history, techniques, and training paths	7
Promoting gender diversity and ergonomic equity in the cardiac surgery operating room	7
Symptoms, coronary artery disease and percutaneous coronary intervention: connecting the dots	7
Improving diversity in cardiac surgery clinical trials with ROMA:Women as an exemplar	7
Destination LVAD therapy in the current era of the heart transplant allocation system	7
When should the tricuspid valve be repaired during mitral valve repair?	7
Transcatheter pulmonary valve replacement: what we know, what we still want to know	7
Percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation: who should receive it in current clinical practice?	7
Artificial sweeteners and cardiovascular risk	7
New wrinkles in hypertension management 2022	7
Editorial introductions	7
Disparity issues in coronary artery surgery	7
How to deal with nonsevere stenoses in coronary artery bypass grafting – a critical perspective on competitive flow and surgical precision	6
Clinical impact of genetic testing for lipid disorders	6
Mitral valve surgery after failed transcatheter edge-to-edge repair: a review and word of caution	6
High lipoprotein(a) is a risk factor for peripheral artery disease, abdominal aortic aneurysms, and major adverse limb events	6
Long noncoding RNAs in cardiovascular disease	6
Management of pregnancy in left ventricular assist device and heart transplant recipients: a concise review	6
Influenza vaccination in mitigating vascular events and risk	6
Coronary artery calcium and sudden cardiac death: current evidence and future directions	6
Electronic health strategies to improve medication adherence in patients with cardiometabolic disease: current status and future directions	6
Peripheral arterial disease and hypertension	6
Left main revascularization guidelines: navigating the data	6
Postmyocardial infarction ventricular septal rupture: optimizing surgical timing and repair	5
Building resilient heart center teams	5
Teaching minimally invasive coronary artery bypass grafting: a structured framework for well tolerated adoption and training	5
From remnant cholesterol to lipoprotein(a) – emerging risk factors for cardiovascular diseases beyond low density lipoprotein: Erratum	5
Patient selection in robotic mitral valve surgery	5
The management of new-onset atrial fibrillation in critical illness: an update on current therapeutic options	5
Double outlet right ventricle – the 50% rule has always been about the conus	5
Managing and predicting electrical and mechanical failure in the systemic right ventricle	5
Editorial introductions	5
Hypertension in atherosclerotic cardiovascular disease: insights into epidemiology, management strategies, and outcomes	5
CRP/hs-CRP lowering by statins and other drugs used to treat dyslipidemia	5
Statin-Associated muscle symptoms and vitamin D supplementation	5

Editorial introductions	5
Pharmacogenetics of cardiovascular drugs	5
Congenitally corrected transposition: not correct at all	5
Editorial: the year in lipids and emerging risk factors	5
Recent advances in cardiac imaging: emerging use of three-dimensional visualization for analyzing complex cardiovascular anatomy	5
Short and long-term complications of hypertensive disorders of pregnancy: lifelong cardiovascular risks we cannot ignore	4
Ultrasound-Based assessment of systemic congestion in pulmonary hypertension	4
Hypertrophic cardiomyopathy and competitive sports: let ‘em play?	4
Beyond Weight Loss: the Emerging Role of Incretin-Based Treatments in Cardiometabolic HFpEF	4
The influence of age and sex on the prognostic importance of traditional cardiovascular risk factors, selected circulating biomarkers and other markers of subclinical cardiovascular damage	4
Closing the care gap: combining enhanced recovery with minimally invasive valve surgery	4
Hypertension in chronic kidney disease and future heart failure	4
Complex issues in coronary artery surgery	4
From C-reactive protein to climate change: risk predictors for cardiovascular diseases beyond low-density lipoprotein cholesterol	4
The role of imaging in risk assessment for pulmonary arterial hypertension	4
Developing a professional and career identity: it's a journey to enjoy	4
Introduction to the coronary artery surgery section	4
Nuclear imaging techniques for cardiac amyloidosis	4
Left ventricular function recovery in Takotsubo syndrome, clinical and pathophysiological insights: a state-of-the-art review	4
Are serum uric acid levels predictors of cardiovascular risk? An update	4
Perspectives on pulsed field ablation: how to judge endpoints	4
The clinical utility of assessing coronary vasomotor dysfunction in angina with nonobstructive coronary artery	4
Editorial: Gene-based renaming of human diseases	4
Risk stratification for sudden death in congenital heart disease: bridging evidence, uncertainty, and individual decision-making	4
Recent advances in multimodal imaging in tetralogy of fallot and double outlet right ventricle	4
Broadening the applicability of coronary surgery from minimally invasive approaches to the modern treatment of ventricular septal rupture	4
Editorial introductions	4
Sutureless aortic valves: timing, technique, and evidence	4
Role of nicotinamide adenine dinucleotide in cardiovascular disease	4
Rethinking atherosclerotic cardiovascular disease prevention in the era of expanding therapies: could plaque stabilization reduce the need for lifelong treatments and polypharmacy?	4
Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease	4